A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin
Open Access
- 31 May 2006
- journal article
- Published by Elsevier BV in Gastrointestinal Endoscopy
- Vol. 63 (6), 808-813
- https://doi.org/10.1016/j.gie.2005.09.033
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- EUS-guided FNAGastrointestinal Endoscopy, 2004
- Low–molecular-weight heparin does not prevent acute post-ERCP pancreatitisGastrointestinal Endoscopy, 2004
- Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNAGastrointestinal Endoscopy, 2003
- EUS-guided fine-needle aspiration of the pancreas: Evaluation of pancreatitis as a complicationGastrointestinal Endoscopy, 2002
- Difficult pancreatic mass FNA: Tips for successGastrointestinal Endoscopy, 2002
- Maximizing the yield of EUS-guided fine-needle aspirationGastrointestinal Endoscopy, 2002
- Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic proceduresGastrointestinal Endoscopy, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDsGastrointestinal Endoscopy, 1994
- Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in RabbitsaAnnals of the New York Academy of Sciences, 1989